Cutting edge: flow cytometry in myelodysplastic syndromes | Aplastic Anemia & MDS International Foundation Return to top.

Cutting edge: flow cytometry in myelodysplastic syndromes

Journal Title: 
J Natl Compr Canc Netw
Primary Author: 
van de Loosdrecht AA
van de Loosdrecht AA, Westers TM
Original Publication Date: 
Monday, July 1, 2013

Flow cytometry (FC) is recognized as one of the important tools in the diagnosis of myelodysplastic syndromes (MDS), especially when cytomorphology and cytogenetics are inconclusive. Minimal requirements to analyze dysplasia using FC have been proposed by the International Workshops from the European LeukemiaNet on Standardization of FC in MDS. These should enable a categorization of FC results in cytopenic patients as "normal," "suggestive of," or "indicative of" MDS. Notably, FC should be considered as part of an integrated diagnosis, rather than as a separate technique. This article highlights tools to implement FC in the diagnostic workup of MDS. Current advances in FC for diagnosis and prognosis of MDS are also introduced.

Bone Marrow Disease(s): 
  • myelodysplastic syndromes (MDS)
Share with